This inventor holds 5 USPTO granted patents and 4 EPO patents. Top assignees: Sanofi, Sanofi-A Ventis Deutschland Gmbh. Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Frankurt, DE (2012)
- Frankfurt-am-Main, DE (2014 - 2018)
Company Filing History:
Years Active: 2012-2018
Title: Gerhard Kretzschmar: Innovator in Pharmaceutical Chemistry
Introduction
Gerhard Kretzschmar is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. With a total of 5 patents, Kretzschmar has established himself as a key figure in the industry.
Latest Patents
Kretzschmar's latest patents include a process for the preparation of ramipril, which details an enantioselective method for producing (2S,3aS,6aS)-cyclopenta[b]pyrrole-2-carboxylic acid and its conversion into ramipril. Another significant patent involves oxathiazine derivatives substituted with carbocycles or heterocycles, which are suitable for treating hyperglycemia. This invention relates to compounds of formula (I) and their physiologically acceptable salts.
Career Highlights
Throughout his career, Kretzschmar has worked with prominent companies in the pharmaceutical sector, including Sanofi and Sanofi-Aventis Deutschland GmbH. His work has focused on developing innovative solutions that address critical health issues.
Collaborations
Kretzschmar has collaborated with esteemed colleagues such as Kai Rossen and Volker Kraft. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Gerhard Kretzschmar's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of effective treatments for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

